Top Markets
#1 Black Phoenix Black Phoenix +21,516.53%
#2 Nesa Nesa +738.21%
#3 Kinesis Silver Kinesis Silver +55.68%
#4 Derive Derive +25.17%
#5 BNB Attestation Service BNB Attestation Service +24.37%
#6 QuantixAI QuantixAI +23.11%
#7 EXOD EXOD +22.78%
#8 Biconomy Biconomy +21.08%
#9 Magma Finance Magma Finance +17.12%
#10 Alchemist AI Alchemist AI +15.29%
Coin of the day
Black Phoenix Black Phoenix
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
BioInvent International AB (publ) BioInvent International AB (publ)

BioInvent International AB (publ)

BINV
Classement en actions #19087
BioInvent International AB (publ) is a clinical-stage Swedish company dedicated... BioInvent International AB (publ) is a clinical-stage Swedish company dedicated to discovering, researching, and developing immunomodulatory antibodies for global cancer treatment, with reach across Sweden, Europe, the United States, and Japan. Its most advanced therapeutic candidate, BI-1206, targets non-Hodgkin lymphoma and various solid tumors. The company's diverse pipeline also features developments aimed at tumor-associated myeloid cells and cancer-associated regulatory T cells, which play a role in modulating the immune system, alongside BT-001 for solid tumors. Furthermore, BioInvent is progressing BI-1808 and BI-1910, a pair of anti-TNFR2 antibodies, designed to combat solid tumors and cutaneous T-cell lymphoma. Strategic collaborations are integral to its operations; these include a partnership with Pfizer Inc. for antibody development against tumor-associated myeloid cells, a co-development effort with Transgene involving multi-functional oncolytic viruses for solid tumors, and an agreement with Merck for the clinical advancement and supply of BI-1808. Established in 1996, BioInvent is based in Lund, Sweden.
Prix de l'action
$2.64
Capitalisation boursière
$173.83M
Changement (1 jour)
-2.67%
Changement (1 an)
-24.04%
Pays
SE
Échange BioInvent International AB (publ) (BINV)

Catégorie

Healthcare
Historique des dividendes pour BioInvent International AB (publ) (BINV)
BioInvent International AB (publ) (symbole boursier : BINV) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour BioInvent International AB (publ) (BINV) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
0.00%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
64.00%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00%
CH